Unexpected Interruptions in the Inhaled Epoprostenol Delivery System: Incidence of Adverse Sequelae and Therapeutic Consequences in Critically Ill Patients

OBJECTIVES:. Inhaled epoprostenol is a continuously delivered selective pulmonary vasodilator that is used in patients with refractory hypoxemia, right heart failure, and postcardiac surgery pulmonary hypertension. Published data suggest that inhaled epoprostenol administration via vibrating mesh ne...

Full description

Saved in:
Bibliographic Details
Main Authors: Jason M. Block, MD, Jai Madhok, MD, MSE, Clark G. Owyang, MD, Kristen R. Merriman, RRT, MS, Stephen J. Ruoss, MD, Vidya K. Rao, MD, MBA
Format: article
Language:EN
Published: Wolters Kluwer 2021
Subjects:
Online Access:https://doaj.org/article/d02882f54f5f44c8a41c4308b1fab05d
Tags: Add Tag
No Tags, Be the first to tag this record!